SAMSUNG BIOLOGICS CO.,LTD. (207940) · Rights issue ·
[Amended]
SAMSUNG BIOLOGICS CO.,LTD. to raise equity via a rights issue followed by a public offering of unsubscribed shares
Original title: [기재정정]주요사항보고서(유상증자결정)
SAMSUNG BIOLOGICS CO.,LTD. disclosed a board resolution dated 2026-08-28 to raise new equity through a rights issue followed by a public offering of unsubscribed shares, issuing 2,270,000 shares of new common stock at a preliminary KRW 1.17 million per share, for total proceeds of about KRW 2.66 trillion. The new shares represent 4.9% of the 46,290,951 shares outstanding before the offering, and the proceeds are earmarked for the acquisition of other companies' securities. Subscription runs from 2026-11-09 to 2026-11-10, with payment due on 2026-11-17 and listing scheduled for 2026-11-30. Any shares left unsubscribed will be offered to the general public from 2026-11-12 to 2026-11-13, and the issue price will be finalised shortly before subscription begins.
Key numbers (extracted from the filing)
| Item | Value |
|---|---|
| New common shares | 2,270,000 shares |
| Par value per share | KRW 2,500 per share |
| Common shares outstanding before the offering | 46,290,951 shares |
| Use of proceeds — Acquisition of other companies' securities | KRW 2.66 trillion |
| Total amount to be raised(calculated) | KRW 2.66 trillion |
| Issue price per common share | KRW 1.17 million per share |
| New common shares as % of shares before the offering(calculated) | 4.9% |
Key dates
| Subscription starts | |
|---|---|
| Subscription ends | |
| General public offering subscription starts | |
| General public offering subscription ends | |
| Payment date | |
| Listing date of new shares | |
| Board resolution date |
Filing facts
Each fact is a condition checked by code against the figures in this filing; hover for the rule and source. It is not an assessment of the company or the filing.
Summary generated by claude-haiku-5-5; created 6 Nov 2026, 11:41 KST.
Receipt no. 20261105000355
More filings from SAMSUNG BIOLOGICS CO.,LTD.
Other filing (Korean only)
Original title: [기재정정]주요사항보고서(타법인주식및출자증권양수결정)
Other filing (Korean only)
Original title: [기재정정]타법인주식및출자증권취득결정(종속회사의주요경영사항)
Other filing (Korean only)
Original title: [기재정정]투자설명서
Other filing (Korean only)
Original title: [발행조건확정]증권신고서(지분증권)
Other filing (Korean only)
Original title: 유상증자신주발행가액(안내공시)
Source data: DART (Data Analysis, Retrieval and Transfer System), Financial Supervisory Service of Korea — original filing.